Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2002-11-08
2009-12-22
Arnold, Ernst V (Department: 1616)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009300, C424S009400, C424S009600
Reexamination Certificate
active
07635464
ABSTRACT:
The invention relates to a method of selectively targeting an active agent (or agent capable of becoming an active agent) to apoptotic cells in a vertebrate, comprising administering to said vertebrate a system comprising an arsenoxide (or arsenoxide equivalent) compound and said agent, wherein said system selectively targets apoptotic cells.
REFERENCES:
patent: 3883659 (1975-05-01), Friedheim et al.
patent: 2 781 674 (1998-07-01), None
patent: WO 98/51297 (1998-11-01), None
patent: WO 99/18798 (1999-04-01), None
patent: WO 99/55344 (1999-11-01), None
patent: WO 00/56742 (2000-09-01), None
patent: WO 01/21628 (2001-03-01), None
Donoghue et al. Protein Science 2000, 9, 2436-2445.
Namgung et al. The Journal of Neuroscience 2000, 20(17), 6442-6451.
Loiseau et al. Antimicrobial Agnets and Chemotherapy 2000, 44(11), 2954-2961.
PCT/AU02/01523, ISR, International Search Report.
Bazarbachi, et al., “Aresenic Trioxide and Interferon-α Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I-Transformed Cells”,Blood, vol. 93, No. 1 (Jan. 1), 1999: pp. 278-283.
Fairlamb, Alan H., et al., “Trypanothione is the Primary Target for Arsenical Drugs Against African Trypanosomes,”PNAS, vol. 86 (1989) pp. 2607-2611.
Fairlamb, Alan H. & Cerami, Anthony, “Metabolism and Functions of Trypanothione in the Kinetoplastida,”Annu. Rev. Microbiol., vol. 46 (1992) pp. 695-729.
Cunningham, Mark L., et al., “Mechanism of inhibition of Trypanothione Reductase and Glutathione Reductase by Trivalent Organic Arsenicals,”FEBS, vol. 221 (1994) pp. 285-295.
Bhargava, Kuldeep K., et al., “Effect of Arsenical Drugs on Glutathione Metabolism ofLitomosoides carinii,” Molecular and Biochemical Parasitology, vol. 9 (1983) pp. 29-35.
Carter, Nicola S. & Fairlamb, Alan H., “Arsenical-Resistant Trypanosomes Lack an Unusual Adenosine Transporter,”Nature, vol. 361 (1993) pp. 173-176.
Pisciotto, Patricia T. & Graziano, Joseph H., “Induction of Mucosal Glutathione Synthesis by Arsenic,”Biochemical et Biophysica Acta, vol. 628 (1980) pp. 241-243.
Lawrence, David A., et al., “Surface Thiols of Human Lymphocytes and Their Changes after in Vitro and In Vivo Activation,”Journal of Leukocyte Biology, vol. 60, (1996) pp. 611-618.
Ryser, Hugues J.-P., et al., “Cell Surface Sulfhydryls are Required for the Cytotoxicity of Diphtheria Toxin but not of Ricin in Chinese Hamster Ovary Cells,”Journal of Biological Chemistry, vol. 266, No. 28 (1991) pp. 18439-18442.
Mandel, Richard, et al., “Inhibition of a Reductive Function of the Plasma Membrane by Bacitracin and Antibodies Against Protein Disulfide-Isomerase,”PNAS, vol. 90 (1993) pp. 4112-4116.
Couët, Jacques, et al., “Cell Surface Protein Disulfide-Isomerase is Involved in the Shedding of Human Thyrotropin Receptor Ectodomain,”Biochemistry, vol. 35 (1996) pp. 14800-14805.
Krishna Rao, A. S. M. & Hausman, R. E., “cDNA for R-Cognin: Homology with a Multifunctional Protein,”PNAS, vol. 90 (1993) pp. 2950-2954.
Zai, Adrian, et al., “Cell-Surface Protein Disulfide Isomerase Catalyzes Transnitrosation and Regulates Intracellular Transfer of Nitric Oxide,”The Journal of Clinical Investigation, vol. 103, No. 3 (1999) pp. 393-399.
Essex, David W., et al., “Localization of Protein Disulfide Isomerase to the External Surface of the Platelet Plasma Membrane,”Blood, vol. 86, No. 6 (1995) pp. 2168-2173.
Essex, David W., et al., “Protein Disulphide Isomerase Mediates Platelet Aggregation and Secretion,”British Journal of Haematology, vol. 104 (1999) pp. 448-454.
Täger, Michael, et al., “Membrane-Bound Proteindisulfide Isomerase (PDI) is Involved in Regulation of Surface Expression of Thiols and Drug Sensitivity B-CLL Cells,”Experimental Hematology, vol. 25 (1997) pp. 601-607.
Stathakis, Paul, et al., “Generation of Angiostatin by Reduction and Proteolysis of Plasmin: Catalysis by a Plasmin Reductase Secreted by Cultured Cells,”J. Bio. Chem., vol. 272, No. 33 (1997) pp. 20641-20645.
Stathakis, Paul, et al., “Angiostatin Formation Involves Disulfide Bond Reduction and Proteolysis in Kringle 5 of Plasmin,”J. Bio. Chem., vol. 274, No. 13 (1999) pp. 8910-8916.
Bannai, Shiro & Tsukeda, Hohko, “The Export of Glutathione from Human Diploid Cells in Culture,”J. Bio. Chem., vol. 254, No. 9 (1979) pp. 3444-3450.
Holmgren, Arne, “Thioredoxin and Glutaredoxin Systems,”J. Bio. Chem., vol. 264, No. 24 (1989) pp. 13963-13966.
Rosén, Anders, et al., “A CD4+T Cell Line-Secreted Factor, Growth, Promoting for Normal and Leukemic B Cells, Identified as Thioredoxin,”International Immunology, vol. 7, No. 4 (1995) pp. 625-633.
Happersberger, Peter H., & Glocker, Michael O., “A Mass Spectrometric Approach to the Characterization of Protein Folding Reactions,”Eur. Mass Spectrom, vol. 4 (1998) pp. 209-214.
Halestrap, Andrew P., et al., “The Permeability Transition Pore Complex: Another View,”Biochimie, vol. 84 (2002) pp. 153-166.
Desagher, Solange & Martinou, Jean-Claude, “Mitochondria as the Central Control Point of Apoptosis,”Trends in Cell Biology, vol. 10 (2000) pp. 369-377.
Fantin, Valeria R., et al., “A Novel Mitochondriotoxic Small Molecule that Selectively Inhibits Tumor Cell Growth,”Cancer Cell, vol. 2 (2002) pp. 29-42.
Belzacq, Anne-Sophie, et al., “The Adenine Nucleotide Translocator in Apoptosis,”Biochimie, vol. 84 (2002) pp. 167-176.
McStay, Gavin P., et al., “Role of Critical Thiol Groups on the Matrix Surface of the Adenine Nucleotide Translocase in the Mechanism of the Mitochondrial Permeability Transition Pore,”Biochem. J., vol. 367 (2002) pp. 541-548.
Koch, Alisa Erika, “The Role of Angiogensis in Rheumatoid Arthritis: Recent Developments,”Ann. Rheum. Dis., vol. 59 (2000) pp. 65-71.
Hayes, Andrew J., “Angioneogenesis in Rheumatoid Arthritis,”The Lancet, vol. 354 (1999) pp. 423-424.
Anonymous, “Arthritis: The Aging Populations of Developed Countries are Likely to present a Growing market for Arthritis Therapies,”Nature Biotechnology, vol. 18 (2000) pp. IT12-IT14.
Ades, Edwin W., et al., “HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line,”The Journal of Investigative Dermatology, vol. 99, No. 6 (1992) pp. 683-690.
Andree, Harry A. M., et al., “Blinding of Vascular Anticoagulant α (VACα) to Planar Phospholipid Bilayers,”J. Bio. Chem., vol. 265, No. 9 (1990) pp. 4923-4926.
Blankenberg, F.G. & Strauss, H. W., “Will Imaging of Apoptosis Play a Role in clinical Care? A tale of Mice and Men,”Apoptosis, vol. 6 (2001) pp. 117-123.
Dahmoun, M., et al., “Apoptosis, Proliferation, and Sex Hormone Receptors in Superficial Parts of Human Endometrium at the End of the Secretory Phase,”The Journal of Clinical Endocrinology&Metabolism, vol. 84, No. 5 (1999) pp. 1737-1743.
Daly, John M., et al., “Neu Differentiation Factor Induces ERbB2 Down-Regulation and Apoptosis of ErbB2-Overexpressing Breast Tumor Cells,”Cancer Research, vol. 57 (1997) pp. 3804-3811.
Donoghue, Neil, et al., “Presence of Closely Spaced Protein Thiols on the Surface of Mammalian Cells,”Protein Science, vol. 9, (2000) pp. 2436-2445.
Fisher, Karen L., et al., “Cloning and Expression of Human Tissue Factor cDNA,”Thrombosis Research, vol. 48 (1987) pp. 89-99.
Gottlieb, Roberta A. & Engler, Robert L., “Apoptosis in Myocardial Ischemia-Reperfusion,”Ann. N. Y. Acad. Sci., vol. 874 (1999) pp. 412-426.
Hofstra, Leo, et al., “Visualisation of Cell Death in vivo in Patients with Acute Myocardial Infarction,”The Lancet, vol. 356 (2000) pp. 209-212.
Huang, Xianming, et al., “Tumor
Arnold Ernst V
McDonnell Boehnen & Hulbert & Berghoff LLP
New South Innovations Pty Limited
LandOfFree
Selective targeting of apoptotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective targeting of apoptotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective targeting of apoptotic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059210